These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7879226)
21. Effect of cyclosporine A on the outcome of one-haplotype identical kidney grafts from a living related donor. Papadimitriou M; Vakianis P; Malliara M; Economidou D; Alexopoulos E; Belechri AM; Koukoudis P; Papadopoulou D; Syrganis C; Polymenidis Z Transplant Proc; 1994 Oct; 26(5):2548-9. PubMed ID: 7940786 [No Abstract] [Full Text] [Related]
22. Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients. Oppenheimer F; Cofán F; Flores R; Pais B; Ochs J; Ricart MJ; Vilardell J; Campistol JM; Torregrosa JV Transplant Proc; 1994 Oct; 26(5):2516-7. PubMed ID: 7940773 [No Abstract] [Full Text] [Related]
23. Reduced incidence of chronic rejection in cyclosporine-treated solid organ recipients with donor antigen-specific hyporeactivity. Reinsmoen NL; Hertz MI; Kubo SH; Bolman RM; Matas AJ Transplant Proc; 1994 Oct; 26(5):2558-9. PubMed ID: 7940790 [No Abstract] [Full Text] [Related]
24. Effects of different immunosuppressive protocols on renal hemodynamics of transplanted patients. Abbud-Filho M; Barberato JB; Ramalho HJ; Yamazaki WM; Salgueiro MC; Silva ML; Ribeiro AC; Bezas AG Transplant Proc; 1994 Oct; 26(5):2594-5. PubMed ID: 7940805 [No Abstract] [Full Text] [Related]
26. Role of cyclosporine rescue therapy in steroid resistant rejections. Sharma RK; Elhence R; Kher V; Gupta A; Kumar A; Bhandari M; Agrawal S Transplant Proc; 1994 Oct; 26(5):2556-7. PubMed ID: 7940789 [No Abstract] [Full Text] [Related]
27. Double-therapy vs triple-therapy immunosuppression in cadaveric renal transplants. Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F Transplant Proc; 1994 Oct; 26(5):2546-7. PubMed ID: 7940785 [No Abstract] [Full Text] [Related]
28. Clinical immunosuppressive matrix in organ transplantation. Land W Transplant Proc; 1994 Oct; 26(5):2479-84. PubMed ID: 7940762 [No Abstract] [Full Text] [Related]
29. Effect of tolerance to allogeneic major histocompatibility complex antigens on rejection across minor antigen differences. Smith CV; Fishbein J; Nakajima K; Rosengard BR; Guzzetta PC; Sachs DH Transplant Proc; 1993 Feb; 25(1 Pt 1):364-5. PubMed ID: 8438337 [No Abstract] [Full Text] [Related]
30. Do early cyclosporine levels affect the incidence of acute rejection in renal transplant recipients? Johnson EM; Canafax DM; Gillingham K; Schmidt W; Pandian K; Najarian JS; Matas AJ Transplant Proc; 1996 Apr; 28(2):879. PubMed ID: 8623444 [No Abstract] [Full Text] [Related]
31. Tolerance induction in human kidney retransplantation: impact of repeated HLA mismatches in 156 second renal grafts. Gnant MF; Sautner T; Rosenmayr A; Muehlbacher F Transplant Proc; 1993 Feb; 25(1 Pt 1):319-21. PubMed ID: 8438317 [No Abstract] [Full Text] [Related]
32. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney]. Treĭvish VS; Shoĭkhet IN; Ankova EV Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915 [TBL] [Abstract][Full Text] [Related]
33. Optimal immunosuppressive clinical regimen in liver transplantation. Farges O; Samuel D; Bismuth H Transplant Proc; 1994 Oct; 26(5):2676-8. PubMed ID: 7940838 [No Abstract] [Full Text] [Related]
34. HLA-DR matching is effective in reducing posttransplant costs in renal allograft recipients on triple therapy. Taylor CJ; Bayne AM; Welsh KI; Morris PJ Transplant Proc; 1993 Feb; 25(1 Pt 1):210-1. PubMed ID: 8438273 [No Abstract] [Full Text] [Related]
35. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy. El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298 [TBL] [Abstract][Full Text] [Related]
36. Late onset acute rejection of renal allografts, an indicator of suboptimum cyclosporin dosage. Sumethkul V; Jirasiritham S; Chiewsilp P Transplant Proc; 1996 Jun; 28(3):1461-2. PubMed ID: 8658741 [No Abstract] [Full Text] [Related]
37. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study. Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889 [No Abstract] [Full Text] [Related]
38. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations. Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272 [TBL] [Abstract][Full Text] [Related]
39. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants. Sumrani N; Hong JH; Daskalakis P; Cacciarelli TV; Markell MS; Sommer BG Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888 [No Abstract] [Full Text] [Related]
40. Low dosage of cyclosporine and increased occurrence of chronic rejection in heart-transplanted patients. Mamprin F; Gamba A; Fiocchi R; Merlo M; Senni M; Troise G; Binetti G; Motta T; Parma A; Ferrazzi P Transplant Proc; 1994 Oct; 26(5):2581-2. PubMed ID: 7940800 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]